EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effect of zamicastat on blood pressure and heart rate response to cold pressor test: A double‐blind, randomized, placebo‐controlled study in healthy subjects

Marlene Fonseca iD, Cheila Ribeiro, Guillermo Castilla-Fernández, Helena Gama, Luís Magalhães, Sara Carolina Henriques iD, Nuno Silva, Filipe Pinto, Luís Almeida, Patrício Soares-da-Silva iD

British Journal of Clinical Pharmacology · 2024

DOI: 10.1111/bcp.16167 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Marlene Fonseca und 9 weiteren Autor:innen. Beteiligte Einrichtung: BlueClinical Phase I, Porto, Portugal. Hauptthemen laut MEDLINE: Cold Temperature, Cross-Over Studies, Heart Rate, Blood Pressure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Bial-Portela & Cª S.A..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Dopamine beta‐hydroxylase (DβH) inhibitors, like zamicastat, hold promise for treating pulmonary arterial hypertension. This study aimed to validate the mechanism of action of zamicastat by studying its effect on the overdrive of the sympathetic nervous system (SNS).

Methods

A single‐centre, prospective, double‐blind, randomized, placebo‐controlled, crossover study evaluated the effect of 400 mg zamicastat in 22 healthy male subjects. Cold pressor test (CPT) was performed at screening and each treatment period on Days −1 and 10. Plasma and 24 h‐urine levels of dopamine (DA), epinephrine (EPI) and norepinephrine (NE), and plasma DβH activity, were measured.

Results

Compared to placebo, zamicastat showed a − 4.62 mmHg decrease in systolic blood pressure during the cold stimulus vs . rest phases on Day 10 of CPT ( P = .020). Zamicastat decreased mean arterial pressure response to cold stimulus during CPT (−2.62 mmHg; P = .025). At Day 10, zamicastat significantly increased plasma DA, before CPT (12.63 ng/L; P = .040) and after CPT (19.22 ng/L; P = .001) as well as the estimated plasma EPI change from baseline after CPT ( P = .040). Inhibition of plasma DβH activity ranged from 19.8% to 25.0%. At Day 10, significant reductions in 24‐h urinary excretion of EPI ( P = .002) and NE ( P = .001) were observed. Zamicastat C τ geometric mean ± GSD ranged from 45.86 ± 1.46 ng/mL on Day 3 to 58.64 ± 1.52 ng/mL on Day 10, with moderate inter‐individual variability (CV: 32.6%–36.6%). Steady state was already achieved on Day 6.

Conclusions

Our results demonstrated the effect of zamicastat on the overdrive sympathetic response to cold stimulus, confirming its potential as SNS modulator.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cold TemperatureCross-Over StudiesHeart RateBlood PressureHealthy VolunteersDopamine beta-HydroxylaseHumansMaleDouble-Blind MethodAdultYoung AdultProspective StudiesNorepinephrineSympathetic Nervous SystemDopamineEpinephrine

Stichwörter der Autor:innen

blood pressurecatecholaminescold pressor testheart ratezamicastat

Substanzen

Dopamine beta-HydroxylaseNorepinephrineDopamineEpinephrine

Autor:innen und Institutionen

  • BlueClinical Phase I, Porto, Portugal.
  • Research and Development, Bial-Portela & Cª S.A., Coronado (S. Romao e S. Mamede), Portugal.
  • BIAL R&D Investments, S.A, Portugal.
  • Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal.
  • Department of Biomedicine, Unit of Pharmacology & Therapeutics, Faculty of Medicine, University of Porto, Portugal.
  • MedInUP - Center for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal.

ORCID-Profile: Marlene Fonseca, Sara Carolina Henriques, Patrício Soares-da-Silva

Förderung

  • Bial-Portela & Cª S.A.

Zitieren

APA

Fonseca, M., Ribeiro, C., Castilla-Fernández, G., Gama, H., Magalhães, L., Henriques, S. C., Silva, N., Pinto, F., Almeida, L., & Soares-da-Silva, P. (2024). Effect of zamicastat on blood pressure and heart rate response to cold pressor test: A double‐blind, randomized, placebo‐controlled study in healthy subjects. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16167

Vancouver

Fonseca M, Ribeiro C, Castilla-Fernández G, Gama H, Magalhães L, Henriques SC, et al. Effect of zamicastat on blood pressure and heart rate response to cold pressor test: A double‐blind, randomized, placebo‐controlled study in healthy subjects. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16167

BibTeX
@article{Fonseca2024,
  author = {Fonseca, Marlene and Ribeiro, Cheila and Castilla-Fernández, Guillermo and Gama, Helena and Magalhães, Luís and Henriques, Sara Carolina and Silva, Nuno and Pinto, Filipe and Almeida, Luís and Soares-da-Silva, Patrício},
  title = {Effect of zamicastat on blood pressure and heart rate response to cold pressor test: A double‐blind, randomized, placebo‐controlled study in healthy subjects},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/bcp.16167}
}
Kostenlos starten →